Palvella Therapeutics, Inc. Common Stock (NASDAQ: PVLA) last traded at $122.58, down 4.61% on the session. The quote above updates while this page is open; the figures below are drawn from Palvella Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Palvella Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker PVLA. Its market capitalisation is $1.77 billion.
Valuation measures for Palvella Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.77B |
|---|---|
| Enterprise value | $1.62B |
| Price / book | 8.14 |
| Beta | 1.65 |
Trailing-twelve-month figures tagged in Palvella Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$61.70M |
| EPS (TTM) | -$4.83 |
|---|
| Return on equity | -28.45% |
|---|
| Cash | $187.80M |
|---|
Range and volume for PVLA over the past 52 weeks.
| 52-week high | $161.38 |
|---|---|
| 52-week low | $68.96 |
| Volume | 382.8K |
| Average volume | 213.0K |
| Previous close | $128.51 |
Invest a chosen dollar amount in Palvella Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PVLA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.